DealForma
Depends
Confidence: Medium
Buy if you're a biopharma BD, corp-dev, or investment team needing curated licensing, M&A, and venture comps.
Comparison
DealForma and Evaluate both land on Depends.
Buy if you're a biopharma BD, corp-dev, or investment team needing curated licensing, M&A, and venture comps.
Buy if you are a pharma, biotech or medtech team needing consensus forecasts and drug sales data . it is a category-standard intelligence source.
| Compare | DealForma | Evaluate |
|---|---|---|
| Verdict | Depends | Depends |
| Best for | Biopharma BD teams | Pharma commercial-intelligence teams |
| Who it's not for | Anyone outside biopharma . zero coverage elsewhere | Small teams without enterprise data budgets |
| Privacy | No known public vulnerabilities found in the sources reviewed.12 | No known public vulnerabilities found in the sources reviewed. |
| Support quality | Hands-on case studies, but vendor is tiny | No support evidence. |
| Public sentiment | Independent reviews are scarce; third-party guides praise its curated biopharma focus and its own site shows strong customer testimonials.³ | Public review evidence is too thin to characterize user sentiment reliably. |
| Biggest gotcha | ~$18K individual seat; team pricing likely quote-based . confirm costs before demo³ | Guess: quote-based enterprise pricing . expect annual contracts and procurement-led negotiation |